Pediatr. praxi. 2020;21(2):113-116 | DOI: 10.36290/ped.2020.022

Gastric Burkitt's lymphoma as the cause of sideropenic anemia in a 14 years old boy

MUDr. Anna Baštan, MUDr. Barbora Ludíková, Ph.D., MUDr. Zbyněk Novák, MUDr. Eva Karásková, Ph.D.
Dětská klinika Fakultní nemocnice a Lékařské fakulty Univerzity Palackého Olomouc

Burkitt lymphoma is agressive non-Hodgkin lymphoma. It is formed by mature B cells. It represents 30-50% of all non-Hodgkin lymphoma among pediatric population. Therapeutic outcome is great compared to adult population. Treatment constitutes of chemotherapy including also central nervous system prophylaxis together with biological treatment. In our case report we describe 14 years old boy with severe sideropenic anemia as the first symptom of gastric Burkitt´s lymphoma.

Keywords: anemia, sideropenia, Burkitt's lymphoma.

Published: June 2, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Baštan A, Ludíková B, Novák Z, Karásková E. Gastric Burkitt's lymphoma as the cause of sideropenic anemia in a 14 years old boy. Pediatr. praxi. 2020;21(2):113-116. doi: 10.36290/ped.2020.022.
Download citation

References

  1. Lebl J, Janda J, Pohunek P, Starý J. Klinická pediatrie. Praha: Galén, 2014: 698 s.
  2. Murphy S. Classification, staging and end results of treatment of childhood non‑Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol 7, 332339 (1980).
  3. Kapitančukė M, Vaščiūnaitė A, Augustinienė R, Sakalinskienė J, Kleinotienė G. Primary gastric Burkitt lymphoma‑induced anaemia: a case report and a literature review. Acta medica Litu. 25, 23-30 (2018). Go to original source...
  4. Ladd A, Grosfeld J. Gastrointestinal tumors in children and adolescents. Semin Pediatr Surg 15, 37-47 (2006). Go to original source... Go to PubMed...
  5. Šmardová L. et al. Burkittův lymfom: přehled patofyziologie, diagnostiky a terapie. Transfuze a Hematol. 2008; (14): 131-139.
  6. Swerdlow S. et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. (2017).
  7. Shustik J. et al. Follicular non‑Hodgkin lymphoma grades 3 A and 3 B have a similar outcome and appear incurable with anthracycline‑based therapy. Ann. Oncol. 22, 1164-1169 (2011). Go to original source... Go to PubMed...
  8. Zhang Q, Foucar K. Bone marrow involvement by Hodgkin and non‑Hodgkin lymphomas. Hematol Oncol Clin North Am 23, 873-902 (2009). Go to original source... Go to PubMed...
  9. Gualco G, Weiss L, Harrington JrW, Bacchi C. Nodal diffuse large b‑cell lymphomas in children and adolescents: immunohistochemical expression patterns and c‑myc translocation in relation to clinical outcome. Am J Surg Pathol. 2009; (33) 1815-1822. Go to original source... Go to PubMed...
  10. Zelenetz A, Gordon L, Abramson J. et. al. NCCN Clinical Practice Guidelines in Oncology. B‑cell Lymphomas. National Comprehensive Cancer Network. B‑Cell Lymphomas. Natl. Compr. Cancer Netw. 5, 79-84 (2019).
  11. Chisti MM, Haresh K. How is Burkitt lymphoma characterized in the histologic findings of NHL/B‑cell lymphoma? Medscape (2018). Available at: https://www.medscape.com/answers/202677-89804/how‑is‑burkitt‑lymphoma‑characterized‑in‑the‑histologic‑findings‑of‑nhlb‑cell‑lymphoma.




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.